Repligen (RGEN) Net Cash Flow (2010 - 2026)
Repligen (RGEN) posted quarterly Net Cash Flow of $24.5 million for Q2 2026, up 130.07% year-over-year from $10.6 million in Q2 2025, and up 30.45% quarter-over-quarter from $18.8 million in Q1 2026.
Repligen (RGEN) Net Cash Flow (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Net Cash Flow for 17 consecutive years, with $24.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Net Cash Flow rose 130.07% year-over-year to $24.5 million; the TTM figure through Jun 2026 stood at -$99.5 million (up 4.09% YoY), while the FY2025 annual figure was -$196.3 million, down 3312.67% from the prior year.
- Net Cash Flow advanced to $24.5 million in Q2 2026 per RGEN's latest filing, from $18.8 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $127.3 million in Q4 2023 and bottomed at -$182.8 million in Q4 2025.
- Historically, Net Cash Flow has averaged $1.0 million across 5 years, with a median of $13.9 million in 2022.
- Annual changes were most pronounced in 2022 — Net Cash Flow plunged 2317.88% — and 2024, when it soared 449.04%.
- Repligen's Net Cash Flow stood at -$59.7 million in 2022, then jumped by 313.21% to $127.3 million in 2023, then slumped by 118.96% to -$24.1 million in 2024, then plunged by 657.53% to -$182.8 million in 2025, then surged by 113.39% to $24.5 million in 2026.
- Business Quant data shows RGEN's Net Cash Flow at $24.5 million in Q2 2026, $18.8 million in Q1 2026, and -$182.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 746.50 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -42.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -192.18 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 95.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -84.00 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -160.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 17.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 149.00 Mn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 24.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.48 Mn |
| Jun 30, 2026 | 24.48 Mn |
| Mar 31, 2026 | 18.76 Mn |
| Mar 31, 2026 | 18.76 Mn |
| Dec 31, 2025 | -182.85 Mn |
| Dec 31, 2025 | -182.85 Mn |
| Sep 30, 2025 | 40.08 Mn |
| Sep 30, 2025 | 40.08 Mn |
| Jun 30, 2025 | 10.64 Mn |
| Jun 30, 2025 | 10.64 Mn |
| Mar 31, 2025 | -64.13 Mn |
| Mar 31, 2025 | -64.13 Mn |
| Dec 31, 2024 | -24.14 Mn |
| Dec 31, 2024 | -24.14 Mn |
| Sep 30, 2024 | -26.14 Mn |
| Sep 30, 2024 | -26.14 Mn |
| Jun 30, 2024 | 29.02 Mn |
| Jun 30, 2024 | 29.02 Mn |
| Mar 31, 2024 | 27.37 Mn |
| Mar 31, 2024 | 27.37 Mn |